ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
Bpharma
|
17 |
7.1K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
17
|
7.1K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Burns wound update
|
|
Bpharma
|
2 |
1.0K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Trading Halt
|
|
Bpharma
|
44 |
15K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
44
|
15K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Update on BBB 33 Evaluation and Bolling 4 Drilling
|
|
Bpharma
|
223 |
82K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
223
|
82K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Establishes Strategic Partnership in South-East Asia
|
|
Bpharma
|
51 |
14K |
3 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
51
|
14K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Establishes Strategic Partnership in South-East Asia
|
|
Bpharma
|
51 |
14K |
5 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
51
|
14K
|
5
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
Bpharma
|
270 |
81K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
270
|
81K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Establishes Strategic Partnership in South-East Asia
|
|
Bpharma
|
51 |
14K |
20 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
51
|
14K
|
20
|
|
ASX - By Stock
|
EUR |
Re:
explaination
|
|
Bpharma
|
64 |
27K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
64
|
27K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Bpharma
|
24 |
6.7K |
4 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
24
|
6.7K
|
4
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Quarterly Activities Report and Appendix 5B
|
|
Bpharma
|
33 |
8.2K |
1 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
33
|
8.2K
|
1
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Quarterly Activities Report and Appendix 5B
|
|
Bpharma
|
33 |
8.2K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
33
|
8.2K
|
4
|
|
ASX - By Stock
|
PVE |
Re:
Ann: PVE - Podere Maiar 1 Site Visit and update
|
|
Bpharma
|
13 |
3.6K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
13
|
3.6K
|
0
|
|
ASX - By Stock
|
CRL |
Re:
Ann: Removal from Official List
|
|
Bpharma
|
53 |
29K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
53
|
29K
|
6
|
|
ASX - By Stock
|
BNL |
Re:
Ann: BBB 33 Drilling Completed and Rig Mobilised to Bolling 4
|
|
Bpharma
|
94 |
31K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
94
|
31K
|
3
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Trading Halt
|
|
Bpharma
|
52 |
16K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
52
|
16K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Ph I/II DFI Efficacy Data to Support Site Expansion
|
|
Bpharma
|
34 |
13K |
9 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
34
|
13K
|
9
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Trading Halt
|
|
Bpharma
|
22 |
9.2K |
0 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
22
|
9.2K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Critical Metals Corp. F-4 is Effective
|
|
Bpharma
|
362 |
109K |
0 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
362
|
109K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Driller Arriving on Location to Drill BBB 33
|
|
Bpharma
|
138 |
38K |
2 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
138
|
38K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
EUROA
|
|
Bpharma
|
30 |
8.9K |
2 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
30
|
8.9K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Bolling 4 SESW Drilling Preparation
|
|
Bpharma
|
14 |
4.5K |
3 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
14
|
4.5K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Murdoch Children's R327 Efficacy UTI in-vivo
|
|
Bpharma
|
27 |
11K |
16 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
27
|
11K
|
16
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Pause in Trading
|
|
Bpharma
|
63 |
22K |
0 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
63
|
22K
|
0
|
|
ASX - By Stock
|
KTA |
Re:
Ann: Multiple Pegmatites Drilled at King Tamba
|
|
Bpharma
|
30 |
10K |
5 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
30
|
10K
|
5
|
|
ASX - By Stock
|
LMG |
Re:
Ann: Trading Halt
|
|
Bpharma
|
52 |
22K |
1 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
52
|
22K
|
1
|
|
ASX - By Stock
|
JGH |
Re:
Ann: Jade Records Stunning 104.6m Gas Intersection
|
|
Bpharma
|
5 |
2.9K |
4 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
5
|
2.9K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded Further $11.17m Advanced Overseas Finding
|
|
Bpharma
|
28 |
8.8K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
28
|
8.8K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded Further $11.17m Advanced Overseas Finding
|
|
Bpharma
|
28 |
8.8K |
9 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
28
|
8.8K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Receipt of Notice under Section 249D of the Corporations Act
|
|
Bpharma
|
11 |
5.8K |
5 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
11
|
5.8K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Strategy & Market Update
|
|
Bpharma
|
20 |
12K |
8 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
20
|
12K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
|
|
Bpharma
|
32 |
11K |
6 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
32
|
11K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded Further $11.17m Advanced Overseas Finding
|
|
Bpharma
|
28 |
8.8K |
7 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
28
|
8.8K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded Further $11.17m Advanced Overseas Finding
|
|
Bpharma
|
28 |
8.8K |
20 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
28
|
8.8K
|
20
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: Investor Webinar
|
|
Bpharma
|
30 |
10K |
11 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
30
|
10K
|
11
|
|
ASX - By Stock
|
TG6 |
Re:
Chart
|
|
Bpharma
|
171 |
56K |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
171
|
56K
|
9
|
|
ASX - By Stock
|
5EA |
Re:
A (NASDAQ) Valuation of FEAM
|
|
Bpharma
|
11 |
6.6K |
1 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
11
|
6.6K
|
1
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: High Grade Lithium Hits Continue at Lake Johnston
|
|
Bpharma
|
360 |
150K |
4 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
360
|
150K
|
4
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: High Grade Lithium Hits Continue at Lake Johnston
|
|
Bpharma
|
360 |
150K |
4 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
360
|
150K
|
4
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: High Grade Lithium Hits Continue at Lake Johnston
|
|
Bpharma
|
360 |
150K |
9 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
360
|
150K
|
9
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: High Grade Lithium Hits Continue at Lake Johnston
|
|
Bpharma
|
360 |
150K |
1 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
360
|
150K
|
1
|
|
ASX - By Stock
|
TG6 |
Re:
Chart
|
|
Bpharma
|
171 |
56K |
2 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
171
|
56K
|
2
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Thick, High-Grade Gold Including 7m @ 23.0g/t Au - Mangaroon
|
|
Bpharma
|
107 |
53K |
21 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
107
|
53K
|
21
|
|
ASX - By Stock
|
5EA |
Re:
Ann: Trading Halt
|
|
Bpharma
|
52 |
18K |
2 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
52
|
18K
|
2
|
|
ASX - By Stock
|
5EA |
Re:
Ann: Trading Halt
|
|
Bpharma
|
52 |
18K |
2 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
52
|
18K
|
2
|
|
ASX - By Stock
|
KTA |
Re:
Investor interviews and videos
|
|
Bpharma
|
19 |
7.8K |
6 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
19
|
7.8K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Acurx Pharmaceuticals
|
|
Bpharma
|
28 |
9.5K |
4 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
28
|
9.5K
|
4
|
|
ASX - By Stock
|
5EA |
Re:
Bonuses for Susan Brennan (CEO) and Paul Weibel (CFO)
|
|
Bpharma
|
12 |
6.2K |
2 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
12
|
6.2K
|
2
|
|
ASX - By Stock
|
5EA |
Re:
Ann: Trading Halt
|
|
Bpharma
|
52 |
18K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
52
|
18K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Acurx Pharmaceuticals
|
|
Bpharma
|
28 |
9.5K |
7 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
28
|
9.5K
|
7
|
|